{
 "drug": "Dapsone Gel",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "03/27/2026",
 "dayN": 151,
 "cat": "Dermatology",
 "companies": [
  "Amneal Pharmaceuticals"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "03/27/2026",
   "update_type": "New",
   "initial_posting_date": "03/27/2026",
   "package_ndc": "69238-1627-6",
   "generic_name": "Dapsone Gel",
   "contact_info": "866-525-7270",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA212701"
    ],
    "brand_name": [
     "DAPSONE"
    ],
    "generic_name": [
     "DASPONE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals NY LLC"
    ],
    "product_ndc": [
     "69238-1627"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "TOPICAL"
    ],
    "substance_name": [
     "DAPSONE"
    ],
    "rxcui": [
     "1741905"
    ],
    "spl_id": [
     "0622cdcc-1196-4a2f-8c85-6f34f0f97f9d"
    ],
    "spl_set_id": [
     "fba0b181-077a-4667-bde1-cf9592f120c2"
    ],
    "package_ndc": [
     "69238-1627-6",
     "69238-1627-9"
    ],
    "nui": [
     "N0000175881",
     "M0020791"
    ],
    "pharm_class_epc": [
     "Sulfone [EPC]"
    ],
    "pharm_class_cs": [
     "Sulfones [CS]"
    ],
    "unii": [
     "8W5C518302"
    ]
   },
   "update_date": "03/27/2026",
   "therapeutic_category": [
    "Dermatology"
   ],
   "dosage_form": "Gel",
   "presentation": "Dapsone, Gel, 7.5% (NDC 69238-1627-6)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "To Be Discontinued"
  }
 ]
}